Skip to main content
Premium Trial:

Request an Annual Quote

BioInquire Gets STTR Grant

NEW YORK (GenomeWeb News) – BioInquire, an Athens, Ga.-based bioinformatics company, said today that is has won a $747,000 Phase II Small Business Technology Transfer grant.

The company plans to use the two-year National Institutes of Health grant to continue to develop its ProteoIQ software suite. The software is designed and distributed for use in academic, pharmaceutical, biotechnology, and molecular diagnostic labs that use mass spectrometry proteomics research techniques.

"While software applications exist for validation and quantitation of MS/MS data, no current product adequately addresses the needs of researchers doing large scale clinical proteomics," James Atwood, co-founder and CEO of BioInquire, said in a statement. "The award will allow us to bridge that technology gap by providing a software solution that will enable the comparison of proteomic data across hundreds of patients."

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.